Browse by category

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour

10 hours ago

Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours

12 hours ago

Hanmi claims HM17321 is a 'game-changer' in overcoming GLP-1-associated muscle loss

14 hours ago

Weekly Digest